The costs for rare disease therapies are often very expensive for the patients. While some get help to cover a portion of their high out-of-pocket costs, health insurers have a policy called copay accumulators that prevent the assistance from counting toward the patient's copay or deductible requirements for the year. There is a legislative effort underway in Ohio (House Bill 177) that would address the issue. Sam Cox, State Government Relations Manager with the National Psoriasis Foundation, discusses the issue, the proposed fix and what patients and advocates can do to get involved.
The costs for rare disease therapies are often very expensive for the patients. While some get help to cover a portion of their high out-of-pocket costs, health insurers have a policy called copay accumulators that prevent the assistance from counting toward the patient's copay or deductible requirements for the year. There is a legislative effort underway in Ohio (House Bill 177) that would address the issue. Sam Cox, State Government Relations Manager with the National Psoriasis Foundation, discusses the issue, the proposed fix and what patients and advocates can do to get involved.